Table 1. IP-10, MCP-1, MIP-1α, MIP-1β, RANTES, and VEGF in the vitreous samples of diabetic and control participants (pg/mL).
| Diabetics | Controls | ||
|---|---|---|---|
| Mean +/− SD (Range) | Mean +/− SD (Range) | p-value | |
| IP-10 | 254.84 (311.67) | 78.90 (67.94) | <0.001* |
| 10.00–1290.30 | 10.00–289.33 | ||
| MCP-1 | 1127.14 (738.91) | 700.80 (419.21) | 0.002* |
| 244.27–3330.50 | 86.97–2177.01 | ||
| MIP-1α | ** | ** | - |
| MIP-1β | ** | ** | - |
| RANTES | ** | ** | - |
| VEGF | 954.98 (2315.09) | 37.90 (28.51) | <0.001* |
| 10.00–13258.40 | 10.00–142.63 |
Interferon-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, macrophage inflammatory protein (MIP)-1β, RANTES (regulated upon activation, normal T-expressed and secreted) and vascular endothelial growth factor (VEGF) levels in the vitreous of diabetics and control samples given in picograms per milliliter. The single asterisk (*) indicates significant after Bonferroni correction p<0.006 (α=0.05) and the double asterisk (**) indicates, that the factor was below the detection limit. SD means standard deviation.